<- Go home

Added to YB: 2024-06-10

Pitch date: 2024-06-05

TWST [bullish]

Twist Bioscience Corporation

-40.74%

current return

Author Info

No bio for this author

Company Info

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.

Market Cap

$1.6B

Pitch Price

$52.19

Price Target

N/A

Dividend

N/A

EV/EBITDA

-16.66

P/E

-20.69

EV/Sales

3.93

Sector

Biotechnology

Category

growth

Show full summary:
Twist Bioscience - More than Synthetic Biology $twst

TWST: DNA synthesis company benefiting from biotech boom but not dependent on it. Diverse rev streams: synthetic genes, NGS cancer screening tools, drug discovery. Margins improving to 41-42% in FY23 from economies of scale & Express Genes product. Growth via lower DNA costs expanding market & potential biotech reshoring from China. Risks: falling NGS prices, limited cancer screening market. Valuation high at 8x sales but existing customer spend +18% YoY & option value from drug royalties.

Read full article (7 min)